Sanofi allies with OpenAI, Formation Bio for AI use in drug development / Photo: Kirill KUDRYAVTSEV - AFP/File
-
UK economy slows, hitting government growth plans
-
Primary schools empty as smog persists in Indian capital
-
Palestinians turn to local soda in boycott of Israel-linked goods
-
Typhoon Man-yi bears down on Philippines still reeling from Usagi
-
UK growth slows in third quarter, dealing blow to Labour government
-
Chris Wood hits quickfire double in NZ World Cup qualifying romp
-
Markets struggle at end of tough week
-
China tests building Moon base with lunar soil bricks
-
Film's 'search for Palestine' takes centre stage at Cairo festival
-
Oil execs work COP29 as NGOs slam lobbyist presence
-
Gore says climate progress 'won't slow much' because of Trump
-
'Megaquake' warning hits Japan's growth
-
Stiff business: Berlin startup will freeze your corpse for monthly fee
-
Wars, looming Trump reign set to dominate G20 summit
-
Xi, Biden attend Asia-Pacific summit, prepare to meet
-
Kyrgios to make competitive return at Brisbane next month after injuries
-
Dominican Juan Luis Guerra triumphs at 25th annual Latin Grammys
-
Landslide win for Sri Lanka president's leftist coalition in snap polls
-
Australian World Cup penalty hero Vine takes mental health break
-
As Philippines picks up from Usagi, a fresh storm bears down
-
Tropical Storm Sara pounds Honduras with heavy rain
-
Pepi gives Pochettino win for USA in Jamaica
-
'Hell to heaven' as China reignite World Cup hopes with late winner
-
Rebel attacks keep Indian-run Kashmir on the boil
-
New Zealand challenge 'immense but fantastic' for France
-
Under pressure England boss Borthwick in Springboks' spotlight
-
All Blacks plan to nullify 'freakish' Dupont, says Lienert-Brown
-
TikTok makes AI driven ad tool available globally
-
Japan growth slows as new PM readies stimulus
-
China retail sales pick up speed, beat forecasts in October
-
Asian markets fluctuate at end of tough week
-
Gay, trans people voicing -- and sometimes screaming -- Trump concerns
-
Argentina fall in Paraguay, Brazil held in Venezuela
-
N. Korean leader orders 'mass production' of attack drones
-
Pakistan's policies hazy as it fights smog
-
Nature pays price for war in Israel's north
-
New Zealand's prolific Williamson back for England Test series
-
Mexico City youth grapple with growing housing crisis
-
After Trump's victory, US election falsehoods shift left
-
Cracks deepen in Canada's pro-immigration 'consensus'
-
Xi inaugurates South America's first Chinese-funded port in Peru
-
Tyson slaps Paul in final face-off before Netflix bout
-
England wrap-up T20 series win over West Indies
-
Stewards intervene to stop Israel, France football fans clash at Paris match
-
Special counsel hits pause on Trump documents case
-
Japan's Princess Mikasa, great aunt to emperor, dies aged 101
-
Cricket at 2028 Olympics could be held outside Los Angeles
-
Trump names vaccine skeptic RFK Jr. to head health dept
-
Ye claims 'Jews' controlling Kardashian clan: lawsuit
-
Japan into BJK Cup quarter-finals as Slovakia stun USA
NYSE - LSE
| RBGPF | 100% | 61.84 | $ | |
| CMSC | -0.24% | 24.55 | $ | |
| RYCEF | -4.71% | 6.79 | $ | |
| CMSD | -0.02% | 24.725 | $ | |
| JRI | -0.23% | 13.21 | $ | |
| SCS | -0.75% | 13.27 | $ | |
| NGG | 0.4% | 62.37 | $ | |
| BCC | -1.57% | 140.35 | $ | |
| RELX | -0.37% | 45.95 | $ | |
| RIO | -0.31% | 60.43 | $ | |
| GSK | -2.09% | 34.39 | $ | |
| BCE | -1.38% | 26.84 | $ | |
| VOD | -0.81% | 8.68 | $ | |
| BP | 1.65% | 29.05 | $ | |
| BTI | 0.2% | 35.49 | $ | |
| AZN | -0.38% | 65.04 | $ |
Sanofi allies with OpenAI, Formation Bio for AI use in drug development
French pharmaceutical company Sanofi announced Tuesday a partnership with ChatGPT-founder OpenAI and US biotech firm Formation Bio to accelerate the use of artificial intelligence in developing drugs.
AI is playing an ever greater role in developing new medicines, as well as identifying new applications for existing drugs.
It can be used for example to find new molecules more quickly and to improve clinical tests by vetting which patients would be most likely to respond to treatments.
By combining their resources, the three companies "can reimagine drug development in the pharma industry," said Benjamine Liu, chief executive of Formation Bio.
Sanofi has in recent years cooperated on AI with biotechnology companies such as Owkin, Exscientia, Insilico Medicine, Amunix Pharmaceuticals, Atomwise and Aqemia.
In a statement, Sanofi said: "The three teams will bring together data, software and tuned models to develop custom, purpose-built solutions across the drug development lifecycle."
"Sanofi will leverage this partnership to provide access to proprietary data to develop AI models as it continues on its path to becoming the first biopharma company powered by AI at scale," it said.
OpenAI "will contribute access to cutting-edge AI capabilities, including the ability to fine-tune models, deep AI expertise and dedicated thought partnership and resources."
J.Gomez--AT
